PubRank

Donato Nitti

Author PubWeight™ 168.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol 2008 3.49
2 Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? J Clin Oncol 2007 3.15
3 A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 2008 3.14
4 IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients. J Immunol 2009 2.64
5 Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 2008 2.63
6 Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis. J Natl Cancer Inst 2010 2.56
7 Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial. Dis Colon Rectum 2013 2.52
8 The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 2007 2.42
9 The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis. Clin Cancer Res 2006 2.36
10 A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg 2010 2.27
11 Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases : personal experience and literature meta-analysis. Cancer 2010 2.14
12 cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol 2008 1.93
13 Quantitative real-time PCR: a powerful ally in cancer research. Trends Mol Med 2003 1.88
14 Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J Natl Cancer Inst 2012 1.82
15 Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer. Ann Surg Oncol 2005 1.79
16 Gastrointestinal stromal tumors: from a surgical to a molecular approach. Int J Cancer 2003 1.77
17 Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol 2003 1.75
18 Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis. Ann Surg Oncol 2011 1.69
19 Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients. Ann Surg Oncol 2008 1.65
20 Part I: Vaccines for solid tumours. Lancet Oncol 2004 1.61
21 Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Med Res Rev 2007 1.55
22 Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor Rev 2004 1.55
23 Multivisceral resection for locally advanced gastric cancer: an Italian multicenter observational study. JAMA Surg 2013 1.53
24 Circulating tumor cells: the 'leukemic phase' of solid cancers. Trends Mol Med 2006 1.51
25 Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status. J Natl Cancer Inst 2006 1.51
26 Telomerase and the search for the end of cancer. Trends Mol Med 2012 1.46
27 Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma. Int J Cancer 2005 1.46
28 Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy. J Proteome Res 2008 1.42
29 Randomized trial of intraportal and/or systemic adjuvant chemotherapy in patients with colon carcinoma. J Natl Cancer Inst 2004 1.39
30 Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. BMC Genomics 2013 1.39
31 The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. Cytokine Growth Factor Rev 2004 1.34
32 EUS for the staging of gastric cancer: a meta-analysis. Gastrointest Endosc 2011 1.27
33 Giant fibroadenoma of the breast in adolescents: report of 2 cases. J Pediatr Surg 2009 1.24
34 Patient-reported outcomes after neoadjuvant chemoradiotherapy for rectal cancer: a multicenter prospective observational study. Ann Surg 2011 1.16
35 TNF and cancer: the two sides of the coin. Front Biosci 2008 1.15
36 Gene expression profile of primary gastric cancer: towards the prediction of lymph node status. Ann Surg Oncol 2006 1.12
37 Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease. Clin Cancer Res 2008 1.11
38 Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer. Ann Surg Oncol 2007 1.10
39 Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing. Lab Invest 2010 1.09
40 Adult soft tissue sarcomas: conventional therapies and molecularly targeted approaches. Cancer Treat Rev 2005 1.08
41 The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer. Ann Surg Oncol 2006 1.07
42 Prospective assessment of imaging after preoperative chemoradiotherapy for rectal cancer. Surgery 2010 1.07
43 -174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer. Clin Cancer Res 2003 1.05
44 The prognostic value of serum S100B in patients with cutaneous melanoma: a meta-analysis. Int J Cancer 2008 1.04
45 Vitamin D receptor polymorphisms and the risk of cutaneous melanoma: a systematic review and meta-analysis. Cancer 2008 1.04
46 Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway. Eur J Cancer Prev 2008 1.02
47 Gastric cancer and synchronous hepatic metastases: is it possible to recognize candidates to R0 resection? Ann Surg Oncol 2014 1.01
48 Multiplexed Cell Signaling Analysis of Metastatic and Nonmetastatic Colorectal Cancer Reveals COX2-EGFR Signaling Activation as a Potential Prognostic Pathway Biomarker. Clin Colorectal Cancer 2009 1.00
49 The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. Hum Pathol 2013 1.00
50 Precancerous lesions in the stomach: from biology to clinical patient management. Best Pract Res Clin Gastroenterol 2013 0.99
51 DNA repair gene polymorphisms and risk of cutaneous melanoma: a systematic review and meta-analysis. Carcinogenesis 2009 0.99
52 Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival. J Transl Med 2009 0.99
53 Early HER2 dysregulation in gastric and oesophageal carcinogenesis. Histopathology 2012 0.98
54 Sentinel node status prediction by four statistical models: results from a large bi-institutional series (n = 1132). Ann Surg 2009 0.97
55 Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high-risk cutaneous melanoma. Int J Cancer 2004 0.96
56 Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion. Breast 2006 0.96
57 Cutaneous melanoma in situ: translational evidence from a large population-based study. Oncologist 2011 0.96
58 Sleeve gastrectomy as revisional procedure for failed gastric banding or gastroplasty. Surg Obes Relat Dis 2009 0.95
59 miRNAs in colon and rectal cancer: A consensus for their true clinical value. Clin Chim Acta 2010 0.95
60 Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis. J Clin Oncol 2007 0.94
61 A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation. Pharmacogenet Genomics 2006 0.94
62 Rectal cancer neoadjuvant treatment in elderly patients. Anticancer Res 2006 0.94
63 Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy. Ann Surg Oncol 2011 0.94
64 Increased TIA-1 gene expression in the tumor microenvironment after locoregional administration of tumor necrosis factor-alpha to patients with soft tissue limb sarcoma. Int J Cancer 2003 0.93
65 Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer. Cochrane Database Syst Rev 2009 0.93
66 Follow-up after gastrectomy for cancer: an appraisal of the Italian research group for gastric cancer. Ann Surg Oncol 2014 0.93
67 Unilateral adrenal hyperplasia: a novel cause of surgically correctable primary hyperaldosteronism. Surgery 2012 0.92
68 Feasibility of laparoscopic sleeve gastrectomy as a revision procedure for prior laparoscopic gastric banding. Obes Surg 2006 0.91
69 Oxidative DNA damage in gastric cancer: CagA status and OGG1 gene polymorphism. Int J Cancer 2008 0.91
70 Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. BMC Cancer 2005 0.91
71 Autophagy and apoptosis-related genes in chronic liver disease and hepatocellular carcinoma. BMC Gastroenterol 2012 0.91
72 Targeted therapy for colorectal cancer: mapping the way. Trends Mol Med 2005 0.91
73 Use of quantitative real-time PCR to determine immune cell density and cytokine gene profile in the tumor microenvironment. J Immunol Methods 2003 0.90
74 Epidermal growth factor receptor (EGFR): mutational and protein expression analysis in gastric cancer. Anticancer Res 2006 0.90
75 Laparoscopic distal pancreatectomy: up-to-date and literature review. World J Gastroenterol 2012 0.90
76 NOTCH3 signaling regulates MUSASHI-1 expression in metastatic colorectal cancer cells. Cancer Res 2014 0.89
77 Telomere-specific reverse transcriptase (hTERT) and cell-free RNA in plasma as predictors of pathologic tumor response in rectal cancer patients receiving neoadjuvant chemoradiotherapy. Ann Surg Oncol 2012 0.88
78 The Reliability of Endoscopic Biopsies in Assessing HER2 Status in Gastric and Gastroesophageal Junction Cancer: A Study Comparing Biopsies with Surgical Samples. Transl Oncol 2013 0.88
79 Role of resection margins in patients treated with breast conservation surgery. Cancer 2008 0.88
80 Do perioperative blood transfusions influence prognosis of gastric cancer patients? Analysis of 927 patients and interactions with splenectomy. Ann Surg Oncol 2011 0.88
81 Health-related quality of life outcomes in disease-free survivors of mid-low rectal cancer after curative surgery. Ann Surg Oncol 2008 0.87
82 Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node. Ann Surg Oncol 2008 0.87
83 Hemodynamic and hormonal stress responses to endotracheal tube and ProSeal Laryngeal Mask Airway™ for laparoscopic gastric banding. Anesthesiology 2012 0.87
84 Does resection line involvement affect prognosis in early gastric cancer patients? An Italian multicentric study. World J Surg 2006 0.87
85 Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: a population-based study of 8,177 cases. Surgery 2011 0.86
86 Tumour-localizing and -photosensitising properties of meso-tetra(4-nido-carboranylphenyl)porphyrin (H2TCP). J Photochem Photobiol B 2007 0.86
87 Colorectal liver metastasis: towards the integration of conventional and molecularly targeted therapeutic approaches. Front Biosci 2005 0.86
88 The role of MYH gene in genetic predisposition to colorectal cancer: another piece of the puzzle. Cancer Lett 2008 0.86
89 Kinase substrate protein microarray analysis of human colon cancer and hepatic metastasis. Clin Chim Acta 2005 0.86
90 Cancer vaccine development: on the way to break immune tolerance to malignant cells. Exp Cell Res 2004 0.86
91 Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer. J Clin Oncol 2012 0.86
92 N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma. Ann Surg Oncol 2007 0.85
93 Laparoscopic gastric rebanding for slippage with pouch dilation: results on 29 consecutive patients. Obes Surg 2008 0.85
94 A pilot characterization of human lung NSCLC by protein pathway activation mapping. J Thorac Oncol 2012 0.85
95 A novel 10B-enriched carboranyl-containing phthalocyanine as a radio- and photo-sensitising agent for boron neutron capture therapy and photodynamic therapy of tumours: in vitro and in vivo studies. Photochem Photobiol Sci 2005 0.85
96 Hypoxia-related proteins in patients with rectal cancer undergoing neoadjuvant combined modality therapy. Dis Colon Rectum 2012 0.85
97 5-fluorouracil and weekly oxaliplatin combined with radiotherapy for locally advanced rectal cancer: surgical complications and long-term results. Arch Med Res 2006 0.85
98 The impact of surgery on survival of patients with cutaneous melanoma: revisiting the role of primary tumor excision margins. Ann Surg 2011 0.83
99 Predictive factors of the response of rectal cancer to neoadjuvant radiochemotherapy. Cancers (Basel) 2011 0.83
100 Therapeutics targeting tumor immune escape: towards the development of new generation anticancer vaccines. Med Res Rev 2008 0.83
101 Colorectal cancer vaccines: principles, results, and perspectives. Gastroenterology 2004 0.83
102 Health-related quality of life, faecal continence and bowel function in rectal cancer patients after chemoradiotherapy followed by radical surgery. Support Care Cancer 2009 0.83
103 The SIC-GIRCG 2013 Consensus Conference on Gastric Cancer. Updates Surg 2014 0.83
104 Extent of lymph node dissection for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2015 0.82
105 CTLA-4 blockade and the renaissance of cancer immunotherapy. Biochim Biophys Acta 2013 0.82
106 Operative Link for Gastritis Assessment gastritis staging incorporates intestinal metaplasia subtyping. Hum Pathol 2011 0.82
107 High risk of rectal cancer and of metachronous colorectal cancer in probands of families fulfilling the Amsterdam criteria. Ann Surg 2013 0.82
108 Indefinite for non-invasive neoplasia lesions in gastric intestinal metaplasia: the immunophenotype. J Clin Pathol 2007 0.82
109 Circulating cell-free DNA, SLC5A8 and SLC26A4 hypermethylation, BRAF(V600E): A non-invasive tool panel for early detection of thyroid cancer. Biomed Pharmacother 2013 0.82
110 Hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from gastric adenocarcinoma. Suppl Tumori 2003 0.82
111 A ten markers panel provides a more accurate and complete microsatellite instability analysis in mismatch repair-deficient colorectal tumors. Cancer Biomark 2010 0.81
112 Evaluation of cell-free DNA as a biomarker for pancreatic malignancies. Int J Biol Markers 2015 0.81
113 IL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections. Clin Chim Acta 2007 0.81
114 Long-term results of melphalan-based isolated limb perfusion with or without low-dose TNF for in-transit melanoma metastases. Ann Surg Oncol 2010 0.81
115 Towards the development of tumor necrosis factor (TNF) sensitizers: making TNF work against cancer. Curr Pharm Des 2007 0.81
116 Long-term oncologic results and complications after preoperative chemoradiotherapy for rectal cancer: a single-institution experience after a median follow-up of 95 months. Ann Surg Oncol 2009 0.80
117 A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients. Cancer Biol Ther 2015 0.80
118 Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing's syndrome. Surgery 2012 0.80
119 Correlation between magnetic resonance imaging and histopathological tumor response after neoadjuvant chemotherapy in breast cancer. Tumori 2008 0.80
120 Non-invasive neoplasia of the stomach. Eur J Gastroenterol Hepatol 2005 0.79
121 An investigation on the nature of the peptide at m/z 904, overexpressed in plasma of patients with colorectal cancer and familial adenomatous polyposis. J Mass Spectrom 2007 0.79
122 Support vector machine learning model for the prediction of sentinel node status in patients with cutaneous melanoma. Ann Surg Oncol 2006 0.79
123 Psychological well-being outcomes in disease-free survivors of mid-low rectal cancer following curative surgery. Psychooncology 2010 0.79
124 MALDI-MS-NIST library approach for colorectal cancer diagnosis. Rapid Commun Mass Spectrom 2009 0.79
125 Celiomesenteric trunk aneurysm. Ann Vasc Surg 2008 0.79
126 DNA array-based gene profiling: from surgical specimen to the molecular portrait of cancer. Ann Surg 2005 0.79
127 Circulating tumor cells in solid cancer: tumor marker of clinical relevance? Curr Oncol Rep 2008 0.78
128 Multivariate analysis approach to the plasma protein profile of patients with advanced colorectal cancer. J Mass Spectrom 2006 0.78
129 Multiplexed protein signal pathway mapping identifies patients with rectal cancer that responds to neoadjuvant treatment. Clin Colorectal Cancer 2012 0.78
130 Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal sarcomatosis: long-term outcome from a single institution experience. Anticancer Res 2013 0.78
131 RNA interference: ready to silence cancer? J Mol Med (Berl) 2005 0.78
132 Tumoural specimens for forensic purposes: comparison of genetic alterations in frozen and formalin-fixed paraffin-embedded tissues. Int J Legal Med 2010 0.78
133 Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterations. Clin Exp Metastasis 2012 0.78
134 Survivin and laryngeal carcinoma prognosis: nuclear localization and expression of splice variants. Histopathology 2012 0.78
135 TNF-based isolated limb perfusion followed by consolidation biotherapy with systemic low-dose interferon alpha 2b in patients with in-transit melanoma metastases: a pilot trial. Ann Surg Oncol 2008 0.78
136 Primary rectal carcinoma in patients with stage IV resectable disease at diagnosis. Anticancer Res 2007 0.78
137 TNFalpha-based isolated perfusion for limb-threatening soft tissue sarcomas: state of the art and future trends. J Immunother 2003 0.78
138 Hepatic arterial infusion for unresectable colorectal liver metastases combined or not with systemic chemotherapy. Anticancer Res 2009 0.78
139 Lesions indefinite for intraepithelial neoplasia and OLGA staging for gastric atrophy. Am J Clin Pathol 2012 0.78
140 Usefulness of MALDI-TOF/MS identification of low-MW fragments in sera for the differential diagnosis of pancreatic cancer. Pancreas 2013 0.77
141 PKH26 staining defines distinct subsets of normal human colon epithelial cells at different maturation stages. PLoS One 2012 0.77
142 Positive experience of intraperitoneal chemotherapy followed by intravenous chemotherapy in heavily pretreated patients with suboptimal residual ovarian cancer and primary peritoneal cancer. Tumori 2011 0.77
143 Glutathione S-transferase P1 Ile105Val polymorphism is associated with haematological toxicity in elderly rectal cancer patients receiving preoperative chemoradiotherapy. Drugs Aging 2008 0.77
144 Molecular oncology in the post-genomic era: the challenge of proteomics. Trends Mol Med 2004 0.77
145 Significance of pulmonary nodules in patients with colorectal cancer. Eur Radiol 2012 0.77
146 Induction of endothelial nitric oxide synthase expression by melanoma sensitizes endothelial cells to tumor necrosis factor-driven cytotoxicity. Clin Cancer Res 2004 0.77
147 Hypoxic antiblastic stop-flow limb perfusion: clinical outcome and pharmacokinetic findings of a novel treatment for in transit melanoma metastases. Oncol Rep 2004 0.77
148 APC I1307K mutations and forkhead box gene (FOXO1A): another piece of an interesting correlation. Int J Biol Markers 2012 0.77
149 True versus mild hyperthermia during isolated hepatic perfusion: effects on melphalan pharmacokinetics and liver function. World J Surg 2004 0.77
150 Correlation between melphalan pharmacokinetics and hepatic toxicity following hyperthermic isolated liver perfusion for unresectable metastatic disease. Ann Surg Oncol 2006 0.77
151 Clinical predictive circulating peptides in rectal cancer patients treated with neoadjuvant chemoradiotherapy. J Cell Physiol 2015 0.76
152 Outcome of surgical treatment of primary aldosteronism. Langenbecks Arch Surg 2015 0.76
153 MINT31 methylation in gastric noninvasive neoplasia: potential role in the secondary prevention of gastric cancer. Eur J Cancer Prev 2012 0.76
154 Number of metastatic sentinel nodes as predictor of axillary involvement in patients with breast cancer. Breast Cancer Res Treat 2004 0.76
155 Factors affecting the treatment of multiple colorectal adenomas. Surg Endosc 2012 0.76
156 Rectum-sparing surgery may be appropriate for biallelic MutYH-associated polyposis. Dis Colon Rectum 2010 0.76
157 Multiplexed cell signaling analysis of metastatic and nonmetastatic colorectal cancer reveals COX2-EGFR signaling activation as a potential prognostic pathway biomarker. Clin Colorectal Cancer 2009 0.76
158 Comparison between CT volume measurement and histopathological assessment of response to neoadjuvant therapy in rectal cancer. Eur J Radiol 2012 0.75
159 Tumor immunology. Adv Exp Med Biol 2007 0.75
160 Targeted Therapy Database (TTD): a model to match patient's molecular profile with current knowledge on cancer biology. PLoS One 2010 0.75
161 Doxorubicin activity is enhanced by hyperthermia in a model of ex vivo vascular perfusion of human colon carcinoma. World J Surg 2003 0.75
162 Effects of A-line Autoregression Index (AAI) monitoring on recovery after sevoflurane anesthesia for bariatric surgery. Obes Surg 2011 0.75
163 Primary great saphenous vein leiomyosarcoma: report of a case. Surg Today 2008 0.75
164 Patient outcome after complete surgery for retroperitoneal sarcoma. Anticancer Res 2013 0.75
165 Gastric type I carcinoid: a pilot study with human G17DT immunogen vaccination. Cancer Immunol Immunother 2011 0.75
166 Complete and lasting healing of bone melanoma metastasis after hyperthermic limb perfusion. Melanoma Res 2009 0.75
167 Dissecting tumor responsiveness to immunotherapy: the experience of peptide-based melanoma vaccines. Biochim Biophys Acta 2003 0.75